Alyeska Investment Group, L.P. Cabaletta Bio, Inc. Call Options Transaction History
Alyeska Investment Group, L.P.
- $25.4 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CABA
# of Institutions
88Shares Held
74.5MCall Options Held
327KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$12.9 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$11.7 Million0.02% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$9.04 Million0.01% of portfolio
-
Jennison Associates LLC6.02MShares$8.01 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$6.65 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $38.6M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...